Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Krystal Biotech Inc shares valued at $2,019,225 were sold by Krishnan Suma on Jul 14 ’25. At $150.30 per share, Krishnan Suma sold 13,435 shares. The insider’s holdings dropped to 1,443,276 shares worth approximately $288.48 million following the completion of this transaction.
Also, Krishnan Suma sold 13,400 shares, netting a total of over 2,014,015 in proceeds. Following the sale of shares at $150.30 each, the insider now holds 1,512,529 shares.
Before that, Krishnan Suma had sold 3,084 shares from its account. In a trade valued at $465,700, the President, R&D traded Krystal Biotech Inc shares for $151.01 each. Upon closing the transaction, the insider’s holdings decreased to 3,084 shares, worth approximately $301.71 million.
As published in their initiating research note from Jefferies on March 05, 2025, Krystal Biotech Inc [KRYS] has been a Buy and the price target has been revised to $245. Analysts at Citigroup downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in early August. As of November 20, 2023, Goldman has initiated its “Buy” rating for KRYS. Earlier on October 24, 2023, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for KRYS stock.
Analyzing KRYS Stock Performance
On last trading session, Krystal Biotech Inc [NASDAQ: KRYS] plunged -1.66% to $199.88. The stock’s lowest price that day was $194.915, but it reached a high of $204.04 in the same session. During the last five days, there has been a surge of approximately 8.01%. Over the course of the year, Krystal Biotech Inc shares have jumped approximately 13.32%. Shares of the company reached a 52-week high of $212.98 on 11/04/25 and a 52-week low of $122.80 on 05/23/25.
Support And Resistance Levels for Krystal Biotech Inc (KRYS)
According to the 24-hour chart, there is a support level at 195.14, which, if violated, would cause prices to drop to 190.39. In the upper region, resistance lies at 204.40. The next price resistance is at 208.92. RSI (Relative Strength Index) is 64.87 on the 14-day chart, showing neutral technical sentiment.
Is Krystal Biotech Inc subject to short interest?
Stocks of Krystal Biotech Inc saw a sharp steep in short interest on 2025-10-15 dropping by -0.71 million shares to 2.89 million. Data from Yahoo Finance shows that the short interest on 2025-09-15 was 3.6 million shares. A decline of -24.72% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 8.13 of the overall float, the days-to-cover ratio (short ratio) decline to 8.13.
Which companies own the most shares of Krystal Biotech Inc (KRYS)?
In terms of Krystal Biotech Inc share price expectations, FactSet research, analysts set an average price target of 220 in the next 12 months, up nearly 8.24% from the previous closing price of $203.26. Analysts anticipate Krystal Biotech Inc stock to reach 224 by 2025, with the lowest price target being 216. In spite of this, 4 analysts ranked Krystal Biotech Inc stock as Buy at the end of 2025. On October 12, 2023, Citigroup assigned a price target of “a Buy” to the stock and initiated coverage with a $160.
